Epitope mapping of human factor IX inhibitor antibodies
- 1 September 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 88 (1) , 166-173
- https://doi.org/10.1111/j.1365-2141.1994.tb04992.x
Abstract
Summary. We have determined the location of epitopes on the factor IX for three haemophilia B inhibitor antibodies (HB-1, HB-3, HB-7) and a monoclonal anti-factor IX inhibitory antibody (designated 65–10). The main binding region of HB-1, HB-3 and HB-7 was 155YVNSTEAETI164 (residues 155–164), 167NITQSTQSFN176 and 156VNSTEAETI164, respectively. The binding region of 65–10 was 168ITQSTQSFNDFTRVV182, which included the cleavage site (180R-V181) for activation by factor XIa. By neutralization experiments using two peptides, 156VNSTEAETI164 and 167NITQSTQSFN176, the degree of neutralization of anti-factor IX IgG purified by protein A was determined. Neutralization of three antibodies, HB-1, HB-3 and HB-7, in the presence of 10mm of the peptides 156VNSTEAETI164 was 30.1%, 0% and 10.8%, respectively, and in the presence of 4 mm of 167NITQSTQSFN176 it was 0%, 13.5% and 17.3%, respectively. On the other hand, when plasmas of patients instead of purified IgG were used for neutralization, 10 mm of 156VNSTEAETI164 and 4 mm of 167NITQSTQSFN176 failed to neutralize the inhibitor in the plasmas.Keywords
This publication has 24 references indexed in Scilit:
- Identification of O‐linked oligosaccharide chains in the activation peptides of blood coagulation factor XEuropean Journal of Biochemistry, 1993
- Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptideBlood Coagulation & Fibrinolysis, 1992
- CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle seriesHuman Genetics, 1991
- Factor VIIa in the treatment of haemophiliaBlood Coagulation & Fibrinolysis, 1990
- Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitorAmerican Journal of Hematology, 1989
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988
- IgG subclass identification of inhibitors to factor IX in haemophilia B patientsBritish Journal of Haematology, 1988
- Alloantibodies in hemophilia B binding to multiple factor IX epitopesThrombosis Research, 1987
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- Gene deletions in patients with haemophilia B and anti-factor IX antibodiesNature, 1983